ArticleEBioMedicine2026
Multi-omics profiling identifies inosine as a key metabolite associated with embryonic arrest in hydrosalpinx-associated infertility.
Article in EBioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Inosine accumulation in hydrosalpinx fluid: a metabolic barrier to early embryonic development.EBioMedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHydrosalpinx affects 10-30% of infertile women, creating a hostile tubal microenvironment that impairs embryonic development. Although fluid embryotoxicity is recognised, specific toxic metabolites and their molecular mechanisms remain elusive.
methodsWe performed untargeted metabolomics on fallopian tube fluid from 49 patients with hydrosalpinx and 52 controls. The functional impact of the identified key metabolite, inosine, was validated in mouse embryos both in vivo and in vitro. Mechanisms were deciphered using integrated transcriptome and translatome sequencing (T&T-seq), and the inosine-induced embryonic arrest was rescued by the purine nucleoside phosphorylase (PNP) inhibitor forodesine and siPNP.
findingsPurine metabolism was the most significantly upregulated pathway in hydrosalpinx fluid, with inosine being a highly elevated metabolite. Functional studies demonstrated that inosine induced a developmental arrest at the 2- to 4-cell stage in mouse embryos. Multi-omics analysis revealed that inosine disrupted the maternal-to-zygotic transition (MZT) and significantly reduced global translation efficiency, leading to cytoskeletal dysfunction and suppression of zygotic genome activation. Critically, both the PNP inhibitor forodesine and siPNP partially rescued the inosine-induced embryonic arrest.
interpretationOur findings establish inosine accumulation as a key metabolic cause of embryonic arrest in hydrosalpinx, functioning through the disruption of translation efficiency and the MZT process. This study not only provides a mechanistic understanding of tubal factor infertility but also highlights the PNP pathway as a potential target for non-surgical interventions to improve fertility.
fundingNational Key R&D Program of China (2022YFC2702204 and 2023YFA1800300), National Natural Science Foundation of China (NSFC) under the Youth Student Basic Research Project (Grant No. 825B2046), and NSFC (82201838 and 82495190).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.